RSPH Holdings — Invesco S&P 500 Equal Weight Health Care ETF
All 62 reported holdings of Invesco S&P 500 Equal Weight Health Care ETF (RSPH) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Invesco Private Prime Fund | 3.36% | $23.17M |
| Centene Corp. | 2.66% | $18.35M |
| Humana Inc. | 2.46% | $16.95M |
| UnitedHealth Group Inc. | 2.31% | $15.92M |
| Elevance Health, Inc. | 2.31% | $15.91M |
| West Pharmaceutical Services, Inc. | 2.22% | $15.30M |
| Cigna Group (The) | 1.98% | $13.65M |
| CVS Health Corp. | 1.96% | $13.48M |
| Viatris Inc. | 1.90% | $13.11M |
| Mettler-Toledo International Inc. | 1.85% | $12.75M |
| Waters Corp. | 1.85% | $12.74M |
| Bio-Techne Corp. | 1.83% | $12.65M |
| Bristol-Myers Squibb Co. | 1.80% | $12.38M |
| Align Technology, Inc. | 1.79% | $12.34M |
| Incyte Corp. | 1.79% | $12.33M |
| DaVita Inc. | 1.78% | $12.28M |
| Agilent Technologies, Inc. | 1.78% | $12.27M |
| Solventum Corp. | 1.77% | $12.21M |
| Biogen Inc. | 1.77% | $12.18M |
| Charles River Laboratories International, Inc. | 1.76% | $12.11M |
| Edwards Lifesciences Corp. | 1.74% | $12.03M |
| Steris PLC | 1.74% | $12.00M |
| Pfizer Inc. | 1.74% | $11.99M |
| Henry Schein, Inc. | 1.73% | $11.95M |
| Baxter International Inc. | 1.73% | $11.94M |
| Quest Diagnostics Inc. | 1.72% | $11.87M |
| Revvity, Inc. | 1.72% | $11.84M |
| Thermo Fisher Scientific Inc. | 1.72% | $11.84M |
| Zoetis Inc. | 1.71% | $11.76M |
| Labcorp Holdings Inc. | 1.69% | $11.64M |
| Johnson & Johnson | 1.68% | $11.59M |
| Merck & Co., Inc. | 1.67% | $11.52M |
| Eli Lilly and Co. | 1.66% | $11.47M |
| IDEXX Laboratories, Inc. | 1.66% | $11.44M |
| Intuitive Surgical, Inc. | 1.65% | $11.38M |
| AbbVie Inc. | 1.65% | $11.37M |
| IQVIA Holdings Inc. | 1.64% | $11.31M |
| Amgen Inc. | 1.63% | $11.24M |
| Danaher Corp. | 1.63% | $11.24M |
| Becton, Dickinson and Co. | 1.62% | $11.19M |
| Regeneron Pharmaceuticals, Inc. | 1.62% | $11.18M |
| Stryker Corp. | 1.62% | $11.16M |
| Medtronic PLC | 1.62% | $11.15M |
| Universal Health Services, Inc. | 1.61% | $11.07M |
| DexCom, Inc. | 1.60% | $11.01M |
| Gilead Sciences, Inc. | 1.59% | $10.98M |
| Cardinal Health, Inc. | 1.59% | $10.97M |
| ResMed Inc. | 1.58% | $10.92M |
| Cencora, Inc. | 1.56% | $10.78M |
| Zimmer Biomet Holdings, Inc. | 1.56% | $10.78M |
| McKesson Corp. | 1.55% | $10.69M |
| Vertex Pharmaceuticals Inc. | 1.54% | $10.64M |
| Cooper Cos., Inc. (The) | 1.52% | $10.45M |
| GE HealthCare Technologies Inc. | 1.49% | $10.26M |
| Boston Scientific Corp. | 1.47% | $10.14M |
| Abbott Laboratories | 1.46% | $10.09M |
| Moderna, Inc. | 1.46% | $10.06M |
| HCA Healthcare, Inc. | 1.44% | $9.91M |
| Insulet Corp. | 1.28% | $8.83M |
| Invesco Private Government Fund | 1.24% | $8.57M |
| Invesco Government & Agency Portfolio | 0.03% | $237.80K |
| TPG Inc. | 0.00% | $0 |
RSPH overview: performance, fees, allocation and SEC filings